While GLP - 1 drugs have been used so far primarily to manage diabetes and clinical obesity defined as having a body mass index (BMI) above 30 the EY-Parthenon survey confirms that the user base is changing as it grows to include more people with moderate weight problems and those who just want to look slimmer
Still, moving effective GLP-1 therapy out of the syringe and into a tablet is one of the more consequential shifts in obesity care I've followed
(Send your questions to [email protected], or write: Ask the Doctors, c/o UCLA Health Sciences Media Relations, 10960 Wilshire Blvd., Suite 1955, Los Angeles, CA, 90024
Consult your provider for questions about Wegovy
Preclinical studies have suggested that GLP-1 receptors are expressed in thyroid tissue, and animal models have indicated possible anti-inflammatory effects that could theoretically influence autoimmune processes
Nat Metab 5(2):186192